NLS Intellectual Property

Nykode Therapeutics has been granted a new US patent covering its individualized neoantigen cancer vaccine VB10.NEO and related modular vaccine designs, strengthening the company's intellectual property position as the neoantigen vaccine field gains momentum.

Klaria has received notification of patent approval from the European Patent Office regarding the second patent in the patent portfolio for Sumatriptan Alginate Film (SAF).

The Patent Trial and Appeal Board (PTAB) of the United States Patent and Trademark Office (USPTO) has issued a favorable Decision on Appeal in U.S. patent application No. 18/065,702, Appeal No. 2026-000924, relating to an immediate-release solid oral dosage formulation of resomelagon (AP1189 acetate).

Medivir has received a Notice of Allowance from the US Patent and Trademark Office for its patent application covering the combination of fostroxacitabine bralpamide (fostrox) and lenvatinib in hepatocellular carcinoma and liver metastases.

A jury in the United States District Court for the District of Massachusetts has delivered a verdict in favor of Abiomed in a patent dispute between Maquet Cardiovascular and Abiomed.

The company has received a patent in the United States for its mucoadhesive patch technology, M045A, developed for the treatment of recurrent aphthous stomatitis (mouth ulcers).